Form 4: Aspen Aerogels Director Receives Annual Equity Grant

Director James E. Sweetnam received an annual equity grant of restricted stock units and stock options as part of Aspen Aerogels' non-employee director compensation policy.

Summary

• Director James E. Sweetnam was granted 10,370 Restricted Stock Units (RSUs) on May 13, 2026.
• The director also received 8,706 stock options with an exercise price of $5.40.
• Both the RSUs and stock options are scheduled to vest on the earlier of May 13, 2027, or the day prior to the 2027 annual meeting of stockholders.
• Following this transaction, the director holds a total of 36,321 shares, consisting of 25,951 common shares and 10,370 RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• The equity grant aligns the director's interests with those of shareholders through long-term incentive compensation.
• The compensation structure follows a standard non-employee director policy, indicating consistent corporate governance practices.

Negatives

• The issuance of additional equity results in minor dilution to existing shareholders.

Risks

• The value of the granted equity is subject to market volatility and the future performance of Aspen Aerogels' common stock.

Future Outlook

The equity grants are subject to standard vesting conditions tied to the director's continued service through the 2027 annual meeting.

Management Comments

• The grants were issued pursuant to the Issuer's Non-Employee Director Compensation Policy.

Industry Context

StockSavvy.ai notes that annual equity grants for non-employee directors are a standard industry practice to ensure board alignment with long-term corporate strategy and shareholder value creation.

Comparison to Industry Standards

• The use of a mix of RSUs and stock options is consistent with compensation packages for directors at mid-cap industrial and technology companies.
• The vesting period of approximately one year aligns with typical annual director compensation cycles.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor dilution from new equity issuance.
• Director: Increased alignment with company performance.

Next Steps

• Vesting of the granted RSUs and stock options on May 13, 2027, or the day prior to the 2027 annual meeting.

Key Dates

Keywords

Aspen Aerogels, ASPN, Director Compensation, Equity Grant, Form 4, Insider Transaction